These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9199349)

  • 21. Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains.
    Kim WY; Sieweke M; Ogawa E; Wee HJ; Englmeier U; Graf T; Ito Y
    EMBO J; 1999 Mar; 18(6):1609-20. PubMed ID: 10075931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional mutagenesis of AML1/RUNX1 and PEBP2 beta/CBF beta define distinct, non-overlapping sites for DNA recognition and heterodimerization by the Runt domain.
    Nagata T; Werner MH
    J Mol Biol; 2001 Apr; 308(2):191-203. PubMed ID: 11327761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AML1-MTG8 leukemic protein induces the expression of granulocyte colony-stimulating factor (G-CSF) receptor through the up-regulation of CCAAT/enhancer binding protein epsilon.
    Shimizu K; Kitabayashi I; Kamada N; Abe T; Maseki N; Suzukawa K; Ohki M
    Blood; 2000 Jul; 96(1):288-96. PubMed ID: 10891464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AML1 fusion transcripts in t(3;21) positive leukemia: evidence of molecular heterogeneity and usage of splicing sites frequently involved in the generation of normal AML1 transcripts.
    Sacchi N; Nisson PE; Watkins PC; Faustinella F; Wijsman J; Hagemeijer A
    Genes Chromosomes Cancer; 1994 Dec; 11(4):226-36. PubMed ID: 7533526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic properties.
    Zent C; Kim N; Hiebert S; Zhang DE; Tenen DG; Rowley JD; Nucifora G
    Curr Top Microbiol Immunol; 1996; 211():243-52. PubMed ID: 8585955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of AML1 during retinoic-acid-induced differentiation of U937 cells.
    Tanaka K; Tanaka T; Ogawa S; Kurokawa M; Mitani K; Yazaki Y; Hirai H
    Biochem Biophys Res Commun; 1995 Jun; 211(3):1023-30. PubMed ID: 7598688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional and physical interactions between AML1 proteins and an ETS protein, MEF: implications for the pathogenesis of t(8;21)-positive leukemias.
    Mao S; Frank RC; Zhang J; Miyazaki Y; Nimer SD
    Mol Cell Biol; 1999 May; 19(5):3635-44. PubMed ID: 10207087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the Runt domain-encoding PEBP2 alpha genes in T cells during thymic development.
    Satake M; Nomura S; Yamaguchi-Iwai Y; Takahama Y; Hashimoto Y; Niki M; Kitamura Y; Ito Y
    Mol Cell Biol; 1995 Mar; 15(3):1662-70. PubMed ID: 7862157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AML1/Runx1 recruits calcineurin to regulate granulocyte macrophage colony-stimulating factor by Ets1 activation.
    Liu H; Holm M; Xie XQ; Wolf-Watz M; Grundström T
    J Biol Chem; 2004 Jul; 279(28):29398-408. PubMed ID: 15123671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physical and functional link of the leukemia-associated factors AML1 and PML.
    Nguyen LA; Pandolfi PP; Aikawa Y; Tagata Y; Ohki M; Kitabayashi I
    Blood; 2005 Jan; 105(1):292-300. PubMed ID: 15331439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of the AML1 proto-oncoprotein in NIH3T3 cells leads to neoplastic transformation depending on the DNA-binding and transactivational potencies.
    Kurokawa M; Tanaka T; Tanaka K; Ogawa S; Mitani K; Yazaki Y; Hirai H
    Oncogene; 1996 Feb; 12(4):883-92. PubMed ID: 8632911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytoplasmic sequestration of the polyomavirus enhancer binding protein 2 (PEBP2)/core binding factor alpha (CBFalpha) subunit by the leukemia-related PEBP2/CBFbeta-SMMHC fusion protein inhibits PEBP2/CBF-mediated transactivation.
    Kanno Y; Kanno T; Sakakura C; Bae SC; Ito Y
    Mol Cell Biol; 1998 Jul; 18(7):4252-61. PubMed ID: 9632809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological characteristics of the leukemia-associated transcriptional factor AML1 disclosed by hematopoietic rescue of AML1-deficient embryonic stem cells by using a knock-in strategy.
    Okuda T; Takeda K; Fujita Y; Nishimura M; Yagyu S; Yoshida M; Akira S; Downing JR; Abe T
    Mol Cell Biol; 2000 Jan; 20(1):319-28. PubMed ID: 10594034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isoforms of the Ets transcription factor NERF/ELF-2 physically interact with AML1 and mediate opposing effects on AML1-mediated transcription of the B cell-specific blk gene.
    Cho JY; Akbarali Y; Zerbini LF; Gu X; Boltax J; Wang Y; Oettgen P; Zhang DE; Libermann TA
    J Biol Chem; 2004 May; 279(19):19512-22. PubMed ID: 14970218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drosophila homologs of the proto-oncogene product PEBP2/CBF beta regulate the DNA-binding properties of Runt.
    Golling G; Li L; Pepling M; Stebbins M; Gergen JP
    Mol Cell Biol; 1996 Mar; 16(3):932-42. PubMed ID: 8622696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A conserved cysteine residue in the runt homology domain of AML1 is required for the DNA binding ability and the transforming activity on fibroblasts.
    Kurokawa M; Tanaka T; Tanaka K; Hirano N; Ogawa S; Mitani K; Yazaki Y; Hirai H
    J Biol Chem; 1996 Jul; 271(28):16870-6. PubMed ID: 8663420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The AML1/ETO fusion protein activates transcription of BCL-2.
    Klampfer L; Zhang J; Zelenetz AO; Uchida H; Nimer SD
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14059-64. PubMed ID: 8943060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Negative regulation of granulocytic differentiation in the myeloid precursor cell line 32Dcl3 by ear-2, a mammalian homolog of Drosophila seven-up, and a chimeric leukemogenic gene, AML1/ETO.
    Ahn MY; Huang G; Bae SC; Wee HJ; Kim WY; Ito Y
    Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1812-7. PubMed ID: 9465099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter.
    Zhang DE; Hetherington CJ; Meyers S; Rhoades KL; Larson CJ; Chen HM; Hiebert SW; Tenen DG
    Mol Cell Biol; 1996 Mar; 16(3):1231-40. PubMed ID: 8622667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.